ACADI March Seminar: How can jellyfish treat kidney disease?

Join us for ACADI’s March seminar as Prof. Kevin Pfleger from The University of Western Australia explains the surprising connection between glowing jellyfish and the search for new treatments for chronic kidney disease.

Have you seen pictures of jellyfish glowing in the dark ocean? In this seminar, Prof. Pfleger will explain how that natural glow has played an unexpected role in helping scientists better understand biological processes connected to chronic kidney disease — and how discoveries inspired by jellyfish have supported the development of potential new therapies.

In this session, Prof. Pfleger will explore:

✨ How bioluminescence in jellyfish has informed scientific discovery

✨ The surprising links between this glow and chronic kidney disease research

✨ How these insights connect to treatment development and innovation

About the speaker:

Professor Kevin Pfleger is Director of Biomedical and Health Innovation at The University of Western Australia and the Western Australian Life Sciences Innovation Hub, and Head of Molecular Endocrinology and Pharmacology at the Harry Perkins Institute of Medical Research. He is a globally recognised molecular pharmacologist, a named inventor on multiple patent families, and former Chief Scientific Officer of spin‑out company Dimerix, now in Phase 3 clinical trials for chronic kidney disease. He is also a scientific co‑founder of RAGE Biotech and mentor to several biotech start‑ups.

📅 Time & date: 2:00 - 3:00pm AEDT | Friday 20 March

📍 Online: via Zoom — link provided upon registration

🔗 Register here: https://go.unimelb.edu.au/47r2

Don’t miss this opportunity to hear from one of Australia’s leading molecular pharmacologists and discover how a glowing jellyfish helped illuminate new possibilities in kidney disease research.